Article Versions Notes

Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Mochly-Rosen D. A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury. Pharmaceuticals. 2022; 15(3):271. https://doi.org/10.3390/ph15030271

Qvit, Nir, Amanda J. Lin, Aly Elezaby, Nicolai P. Ostberg, Juliane C. Campos, Julio C. B. Ferreira, and Daria Mochly-Rosen. 2022. "A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury" Pharmaceuticals 15, no. 3: 271. https://doi.org/10.3390/ph15030271

Qvit, N., Lin, A. J., Elezaby, A., Ostberg, N. P., Campos, J. C., Ferreira, J. C. B., & Mochly-Rosen, D. (2022). A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury. Pharmaceuticals, 15(3), 271. https://doi.org/10.3390/ph15030271